Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omicron-Based CovIran Barkat booster trial in previously vaccinated adults
IRCT20171122037571N4Phase 3Completed
- Sponsor
- Shifa Pharmed
- Start
- Feb 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of BBIBP-CorV in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Shifa Pharmed. Primary endpoints: Humoral immunity, Seroconversion and 3 more. Started Feb 2022; status: completed.
02
Drugs
BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20171122037571N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171122037571N4.